Study wrapper · #1385
Increased Energy Expenditure through Intermittent Cold Exposure Does Not Enhance Tirzepatide Induced Weight-loss in Obese Mice.
Bellucci A, Alfares H, Gale C, et al. American journal of physiology. Regulatory, integrative and comparative physiology. 2026.
DOI: 10.1152/ajpregu.00220.2026PubMed: 42722006
Editor's note
A clean null result on a reasonable hypothesis: boosting energy expenditure through cold-induced thermogenesis did not stack with tirzepatide's intake suppression. The design has strengths — both sexes, controlled diet-induced obesity — but a single mouse dose and a three-week window limit inference, and rodent cold-exposure protocols map poorly onto human behavior. Useful for tempering the 'stack cold plunges with GLP-1s' extrapolations circulating in the community.
Plain-language abstract
In obese mice, adding daily one-hour cold exposure to tirzepatide did not produce more weight loss than tirzepatide alone, though cold exposure on its own improved glucose handling independent of weight.
Related coverage
Weak / none
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Journal of medical economicsn=——2026
Mixed
Sleeve gastrectomy versus tirzepatide to improve survival among patients with stage 5 CKD: A Markov decision analysis.
American journal of surgeryn=——2026
Mixed
Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.
Journal of chromatography. An=——2026